137 related articles for article (PubMed ID: 24767205)
1. [The efficacy and safety of methotrexate in refractory Crohn's disease].
Xu P; He Y; Chen Y; Chao K; Chen B; Mao R; Tang R; Zhu Z; Zeng Z; Chen M
Zhonghua Nei Ke Za Zhi; 2014 Mar; 53(3):188-92. PubMed ID: 24767205
[TBL] [Abstract][Full Text] [Related]
2. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
Huang Z; Chao K; Li M; Zhi M; Tang J; Hu P; Gao X
Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
[TBL] [Abstract][Full Text] [Related]
5. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
Kopylov U; Katsanos KH; van der Woude CJ; Karmiris K; Hernandez V; Odes S; Papamichael K; Koutroubakis IE; Bojic D; Kaimakliotis I; Fiorino G; Papageorgiou N; Pineda JR; Strongili K; Sanroman L; Mantzaris GJ; Jojic N; Paspatis G; Christodoulou DK; Ben-Horin S; Tsianos EV
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634
[TBL] [Abstract][Full Text] [Related]
6. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
7. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
Din S; Dahele A; Fennel J; Aitken S; Shand AG; Arnott ID; Satsangi J
Inflamm Bowel Dis; 2008 Jun; 14(6):756-62. PubMed ID: 18275071
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
Uhlen S; Belbouab R; Narebski K; Goulet O; Schmitz J; Cézard JP; Turck D; Ruemmele FM
Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
Turner D; Grossman AB; Rosh J; Kugathasan S; Gilman AR; Baldassano R; Griffiths AM
Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
[TBL] [Abstract][Full Text] [Related]
12. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
Hafraoui S; Dewit O; Marteau P; Cosnes J; Colombel JF; Modigliani R; Cortot A; Lémann M
Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate in refractory Crohn's disease.
Vandeputte L; D'Haens G; Baert F; Rutgeerts P
Inflamm Bowel Dis; 1999 Feb; 5(1):11-5. PubMed ID: 10028444
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
Rouiller-Braunschweig C; Fournier N; Pittet V; Dudler J; Michetti P
Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's disease.
Schmidt KJ; Fellermann K; Wellhöner P; Weitz G; Homann N; Herrlinger K; Lehnert H; Ludwig D; Büning J
Aliment Pharmacol Ther; 2009 Jun; 29(12):1230-9. PubMed ID: 19302074
[TBL] [Abstract][Full Text] [Related]
17. A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease.
Chande N; Ponich T; Gregor J
Can J Gastroenterol; 2005 Sep; 19(9):553-8. PubMed ID: 16151547
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
Charpignon C; Beau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
Lémann M; Zenjari T; Bouhnik Y; Cosnes J; Mesnard B; Rambaud JC; Modigliani R; Cortot A; Colombel JF
Am J Gastroenterol; 2000 Jul; 95(7):1730-4. PubMed ID: 10925976
[TBL] [Abstract][Full Text] [Related]
20. A single-center experience with methotrexate in the treatment of Chinese Crohn's disease patients.
Wang TR; Qiao YQ; Zou DW; Ran ZH
J Dig Dis; 2018 Dec; 19(12):753-758. PubMed ID: 30516330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
